Evotec SE 2019 SR
The report highlights Evotec's commitment to sustainable drug discovery and development, focusing on employee matters, human rights, and anti-corruption. In 2019, the company's workforce grew to 3,030 employees, with a strong emphasis on diversity and the integration of a 'One Evotec Culture' through new leadership instruments. Evotec achieved AAALAC accreditation for several research sites, demonstrating high standards in animal welfare and the use of iPSC technology to reduce animal testing. The company also launched a global sustainability initiative to address waste, transport, and energy, with plans to implement a CO2 tracking scheme in 2020.
Company: Evotec SE
Sector: Manufacturing
Country: Germany
Year: 2019
Type: SR
Pages: 12
Back to company
Evotec SE
Separate Non-Financial Group Report
The report highlights Evotec's commitment to sustainable drug discovery and development, focusing on employee matters, human rights, and anti-corruption. In 2019, the company's workforce grew to 3,030 employees, with a strong emphasis on diversity and the integration of a 'One Evotec Culture' through new leadership instruments. Evotec achieved AAALAC accreditation for several research sites, demonstrating high standards in animal welfare and the use of iPSC technology to reduce animal testing. The company also launched a global sustainability initiative to address waste, transport, and energy, with plans to implement a CO2 tracking scheme in 2020.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2019 - Dec 31, 2019
Fiscal Year
2019
Published
Mar 16, 2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women in Management
Employees